Subscribe To
Why akero therapeutics stock is crashing today
Akero's experimental NASH drug efruxifermin (EFX) missed its primary endpoint in a phase 2b study. However, statistica...
October 10, 2023, 11:44 am
Honor bank successfully deploys ncino’s commercial banking solution
Michigan-based community bank goes-live on the nCino platform in months, driving a more modern customer experience HONOR, Mich. and WILMINGTON, N.C., ...
October 10, 2023, 11:30 am
Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)
– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specificall...
October 10, 2023, 11:30 am
Electrameccanica vehicles corp. (solo) loses -30.62% in 4 weeks, here's why a trend reversal may be around the corner
The heavy selling pressure might have exhausted for ElectraMeccanica Vehicles Corp. (SOLO) as it is technicall...
October 10, 2023, 11:18 am
Down -17.48% in 4 weeks, here's why insulet (podd) looks ripe for a turnaround
The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold ter...
October 10, 2023, 11:18 am
Down -11.3% in 4 weeks, here's why keurig dr pepper, inc (kdp) looks ripe for a turnaround
The heavy selling pressure might have exhausted for Keurig Dr Pepper, Inc (KDP) as it is technically in...
October 10, 2023, 11:17 am
Down -13.41% in 4 weeks, here's why you should you buy the dip in yeti (yeti)
Yeti (YETI) has become technically an oversold stock now, which implies exhaustion of the heavy selling...
October 10, 2023, 11:17 am
Here's why neogen (neog) is poised for a turnaround after losing -14.43% in 4 weeks
Neogen (NEOG) has become technically an oversold stock now, which implies exhaustion of the heavy selli...
October 10, 2023, 11:17 am
Hyperfine (hypr) progresses in mri space with latest fda nod
Hyperfine's (HYPR) updated Swoop software is expected to make brain imaging more accessible and clinically...
October 10, 2023, 11:16 am
Audusd technical analysis - chances of more upside after the failed breakout
US:The Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher as the economy showed much ...
October 10, 2023, 11:08 am
10%-yielding hercules capital is a bdc superstar
Hercules Capital is a top-tier business development company with a strong track record and a high yield. The company specializes in financing high-gro...
October 10, 2023, 11:00 am
5 dividend stocks for a year-end market rally
September lived up to its billing as the worst month of the year for stocks. According to a report from Bank of America, stocks could be due for a fou...
October 10, 2023, 10:36 am
Quicklogic (quik) is on the move, here's why the trend could be sustainable
QuickLogic (QUIK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamenta...
October 10, 2023, 10:31 am
Annexon announces clinical and regulatory progress for anx005 pivotal program in guillain-barré syndrome (gbs)
ANX005 Granted Orphan Drug Designation by the European Medicines Agency for the Treatment of GBS Target Enrollment Achieved in Phase 3 Pivotal Study o...
October 10, 2023, 10:30 am
1 magnificent nasdaq-100 stock to buy and hold forever
O'Reilly Automotive is ready to launch full speed ahead into Mexico. Its potent profitability and share...
October 10, 2023, 10:23 am
Gbp/usd forecast: pound sterling could test 1.2300 next
The Relative Strength Index (RSI) indicator on the 4-hour chart rose above 60 on Tuesday, pointing to a build-up of bullish momentum. Additiona...
October 10, 2023, 10:14 am
New to fintech? here's why i would buy visa stock first
The broad transition away from cash has helped Visa grow substantially. Visa is proactively involved wi...
October 10, 2023, 10:10 am
3 dividend kings every investor should own to survive a market crash
Dividend stocks have proved time and again to be a superior investing strategy. We all want capital appreciation, or to see our stocks grow in value o...
October 10, 2023, 10:06 am
Merck immunotherapy shows further promise in lung cancer
Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary ...
October 10, 2023, 9:11 am
Nike: leading the race once again
Nike is the leader in consumer sportswear apparel and footwear, with a long history of innovative and market-leading products. Despite recent earnings...
October 10, 2023, 9:05 am